20231564

Source:http://linkedlifedata.com/resource/pubmed/id/20231564

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0009247, umls-concept:C0070166, umls-concept:C0205420, umls-concept:C0243077, umls-concept:C1274040, umls-concept:C1524063
pubmed:issue	6
pubmed:dateCreated	2010-3-16
pubmed:abstractText	Proton-pump inhibitors (PPIs) and clopidogrel are frequently coprescribed, although the benefits and harms of their concurrent use are unclear.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/HL081707, http://linkedlifedata.com/resource/pubmed/grant/HS1-16974, http://linkedlifedata.com/resource/pubmed/grant/R01 HL081707-07
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/20231564-20231571
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0372351
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Platelet Aggregation Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Proton Pump Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Ticlopidine, http://linkedlifedata.com/resource/pubmed/chemical/clopidogrel
pubmed:status	MEDLINE
pubmed:month	Mar
pubmed:issn	1539-3704
pubmed:author	pubmed-author:ChungCecilia PCP, pubmed-author:DaughertyJames RJR, pubmed-author:GriffinMarie RMR, pubmed-author:HallKathiK, pubmed-author:KaltenbachLisa ALA, pubmed-author:MurrayKatherine TKT, pubmed-author:RayWayne AWA, pubmed-author:SmalleyWalter EWE, pubmed-author:SteinC MichaelCM
pubmed:issnType	Electronic
pubmed:day	16
pubmed:volume	152
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	337-45
pubmed:dateRevised	2011-9-26
pubmed:meshHeading	pubmed-meshheading:20231564-Adult, pubmed-meshheading:20231564-Aged, pubmed-meshheading:20231564-Cardiovascular Diseases, pubmed-meshheading:20231564-Cohort Studies, pubmed-meshheading:20231564-Drug Therapy, Combination, pubmed-meshheading:20231564-Female, pubmed-meshheading:20231564-Gastrointestinal Hemorrhage, pubmed-meshheading:20231564-Hospitalization, pubmed-meshheading:20231564-Humans, pubmed-meshheading:20231564-Male, pubmed-meshheading:20231564-Middle Aged, pubmed-meshheading:20231564-Platelet Aggregation Inhibitors, pubmed-meshheading:20231564-Proportional Hazards Models, pubmed-meshheading:20231564-Proton Pump Inhibitors, pubmed-meshheading:20231564-Retrospective Studies, pubmed-meshheading:20231564-Risk Assessment, pubmed-meshheading:20231564-Risk Factors, pubmed-meshheading:20231564-Ticlopidine, pubmed-meshheading:20231564-Treatment Outcome
pubmed:year	2010
pubmed:articleTitle	Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study.
pubmed:affiliation	Vanderbilt University School of Medicine and Veterans Affairs Tennessee Valley Healthcare System, Nashville, Tennessee, USA. Wayne.Ray@vanderbilt.edu
pubmed:publicationType	Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, N.I.H., Extramural